openPR Logo
Press release

Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Disease, Infectious Disease, Cancer, Autoimmune Disease

09-21-2022 11:34 AM CET | Health & Medicine

Press release from: Precision Business Insights

Biopharmaceutical Fermentation Market 2022 | Growing

According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the R&D institutes also promote the adaptation of biopharmaceutical products over traditional treatment choices. Therefore, these new critical developments in the therapeutic trends act as the main driving force for the biopharmaceutical fermentation market expansion in the forecast period.

View the detailed report description here -

The Monoclonal Antibodies Segment to Take the Most Share in the Biopharmaceutical Fermentation Market:
Monoclonal antibodies (MAbs) are protein molecules made in the laboratory from hybridoma cells by recombinant DNA technology. Monoclonal antibodies have been used in the research field for many years but could not be applied as a therapeutic agent due to technological limitations. But recently, with further research and development use of monoclonal antibodies has been increasing. Nowadays, monoclonal antibodies have been approved by FDA for use in therapeutics in diseases like breast cancer, leukemia, asthma, macular degeneration, arthritis, Crohn's disease, transplants, autoimmune diseases, infectious diseases, etc. There are several advantages of using MAbs, of which targeted drug delivery is one of them. With all these advantages and promising results in clinical trials, it can be anticipated that MAbs will mostly replace the traditional drugs for many diseases, which can be attributed to the monoclonal antibody segment contributing the most to the biopharmaceutical fermentation market expansion in the upcoming years.

North American Region to Dominate the Biopharmaceutical Fermentation Market:
According to the analysis of the biopharmaceutical fermentation market, the market overview projects the business in the North American region to flourish the most in the forecast period. This region dominated the market till now, with a total of USD 2,473.4 million in revenue generation. Owing to the favorable business environment due to government policies, key players like Thermo Fisher Scientific expanding their manufacturing and research units in this region. Thus, this region is expected to attract more companies to expand their manufacturing unit in this region for doing business worldwide. Moreover, good scientific support from research institutes in this region due to funding for research and development will also contribute to the attractiveness of this region.

Strategic New Product Launches, Mergers, Acquisitions, And Agreements Are the Key Strategies Adopted by Market Players:
The global Biopharmaceutical Fermentation market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In April 2021, Chr. Hansen has introduced "Fresh DA," a food culture that is used to accelerate the fermentation of products. This will extend the life of these products by delaying the growth of yeasts and molds and avoiding rotting.

Request sample report at:

The biopharmaceutical fermentation market is segmented based on product type, application, end user, and geography
Based On the Product Type, The Market is Segmented into the Following:
• Upstream Process
• Downstream Products

Based On Application, The Market is Segmented into the Following:
• Antibiotics
• Recombinant Proteins
• Monoclonal Antibodies
• Probiotics
• Other Applications

Based On End User, The Market is Segmented into The Following:
• Biopharmaceutical Industries
• Contract Research Organization
• Food Industries
• Academic Research Institutes
• Others

Based On Geography, The Market is Segmented into the Following:
• North America
• Europe
• Asia-Pacific
• Middle East and Asia
• Latin America

Request Methodology:

Key players' profiles in the biopharmaceutical fermentation market are GE Healthcare, Thermo Fisher Scientific Inc., Danaher Corporation, Sartorius Stedim Biotech, Merck KGaA, Eppendorf AG, F. Hoffmann-La Roche Ltd., Nova Biomedicals, Lonza, Becton, Dickinson, and Company.

Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers. Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Disease, Infectious Disease, Cancer, Autoimmune Disease here

News-ID: 2743379 • Views: 555

More Releases from Precision Business Insights

Biodegradable Polymers Market Size and Share | Industry Analysis 2023-2029
The global biodegradable polymers market size was valued at USD 9,235.4 million in 2022 and is poised to grow at a significant CAGR of 23.1% during the forecast period 2023-29. The primary drivers of the expansion of the global biodegradable polymers market include the increasing environmental consciousness among the public influences the demand for sustainable and lowering impact on environment which drives the biodegradable polymers market growth. The increase in
Automated Liquid Handling Market Size and Share | Industry Report 2023-2029
The global automated liquid handling market size was valued at USD 1,281.3 million in 2022 and is poised to grow at a significant CAGR of 9.3% during the forecast period 2023-29. The primary drivers of the expansion of the global automated liquid handling market include the increasing demand for automated liquid handling machine and increased adoption of automated liquid handling systems in clinical and research laboratories. View the detailed report description
Aircraft Coatings Market Size and Share | Industry Report 2023-2029
The global aircraft coatings market size was valued at USD 1,994.6 million in 2022 and is poised to grow at a significant CAGR of 4.7% during the forecast period 2023-29. The primary drivers of the expansion of the global aircraft coatings market include the growing aircraft manufacturing industry, increasing preference of air travel among individuals. Increase in substantial expenditure, and improved standards of living in the developing countries is expected
Excitation Systems Market Research Insights 2023-29
The global excitation systems market size was valued at USD 2,939.4 million in 2022 and is expected to grow at a CAGR 4.3% during the forecast period 2023 to 2029. The primary drivers of the expansion of the global excitation systems market include the increasing demand for excitation systems in reliable operations, increasing renewable energy sources. In addition, growing research and development of digital excitation control systems is expected to

All 5 Releases

More Releases for Biopharmaceutical

Global Biopharmaceutical Stability Testing Market
According to a new market research report published by Global Market Estimates, the Global Biopharmaceutical Stability Testing Market is projected to grow from USD 3.2 billion in 2022 to USD 10.8 billion in 2027 at a CAGR of 13.3% from 2022 to 2027. Intertek Group plc, Eurofins Scientific, Pacific Biolabs, SGS SA, Element Materials Technology, Almac Group, Merck KGaA, Catalent, Inc., Pace Analytical Life Sciences, Boston Analytical, Kemwell Biopharma, Curia Global,
Biopharmaceutical Testing Services Market 2021 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the Biopharmaceutical Testing Services market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading players’ performance based on revenue generation and client requirements. Also, the research report reveals
BioPharmaceutical Tubing Market 2021 | Detailed Report
According to Market Study Report, BioPharmaceutical Tubing Market provides a comprehensive analysis of the BioPharmaceutical Tubing Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of BioPharmaceutical Tubing Market @ The report provides a comprehensive analysis of
Biopharmaceutical Market - Massive Growth opportunity Ahead
A new research document with title 'State of the Biopharmaceutical Industry 2021' covering detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes regions and important players/vendors. The report will help user gain market insights, future trends and growth prospects for forecast period of 2021 Get customization & check discount for report @ Summary 2021 promises to be a year of continued innovation and change in the
Biopharmaceutical Logistics Market Is Thriving Worldwide |
The Biopharmaceutical Logistics Market Research Report aims to provide insights that strongly demonstrate the market structure, scope, history, potential, and development perspective. By crossing through the historical and present market status, the Biopharmaceutical Logistics market report provides authentic and reliable estimates for the forecast period. It became essential to distinguish the saturation of consumption in the Biopharmaceutical Logistics market owing to building competitiveness. Hence, the report furnishes a deep-felt market segmentation
The Future Of Investing: Biopharmaceutical Logistics Market
The pharmaceutical industry is dynamic and is likely to experience high growth in the coming years. Today, growing sales of drugs and biologics, changing dynamics of the pharmaceutical industry, and stringent regulatory controls are some of the factors boosting the demand for pharmaceutical logistics services.  Outsourcing logistics operations are trending in the pharma industry for cost optimization and technology advancement. Pharmaceutical companies are facing tremendous pressure for cutting down the cost of